Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,090 | 37,749 | 51,270 | 62,955 | 70,718 |
| TOTAL | $25,165 | $39,726 | $52,266 | $63,771 | $71,480 |
| Non-Current Assets | |||||
| PPE Net | 169 | 186 | 204 | 222 | 241 |
| Other Non-Current Assets | 200 | 200 | 200 | 200 | 200 |
| TOTAL | $369 | $386 | $404 | $422 | $441 |
| Total Assets | $25,534 | $40,112 | $52,670 | $64,192 | $71,921 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 785 | 2,756 | 1,987 | 1,229 | 488 |
| Accounts payable and accrued liabilities | 1,420 | 4,017 | 6,413 | 2,992 | 1,898 |
| Accrued Expenses | 1,669 | 2,326 | 3,604 | 1,762 | 1,591 |
| TOTAL | $3,875 | $9,100 | $12,021 | $5,991 | $3,976 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,154 | 7,205 | 7,917 | 8,617 | 9,300 |
| TOTAL | $3,154 | $7,205 | $7,917 | $8,617 | $9,300 |
| Total Liabilities | $7,029 | $16,305 | $19,938 | $14,608 | $13,276 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | 1 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -118,858 | -112,832 | -103,317 | -86,055 | -76,577 |
| TOTAL | $18,505 | $23,807 | $32,733 | $49,585 | $58,644 |
| Total Liabilities And Equity | $25,534 | $40,112 | $52,671 | $64,192 | $71,921 |